BROADCASTS.com

b"Every week, The American Journal of Managed Care\\xae recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\\n\\nThis week, the top managed care stories included patient advocates, providers, payers, and pharma commenting on the Trump administration's drug pricing plan; a survey that found physicians and payers believe progress toward value-based care is slowing; a study that questions the standards of evidence for breakthrough therapy approvals.\\n\\nRead more about the stories in this podcast:\\nFrom Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs: https://www.ajmc.com/newsroom/from-patient-advocates-to-pharma-groups-weigh-in-on-trump-blueprint-for-drug-costs\\nNovartis Will Freeze Drug Prices Through End of 2018, CEO Says: https://www.ajmc.com/newsroom/novartis-will-freeze-drug-prices-through-end-of-2018-ceo-says\\nWhat We're Reading: 340B Lawsuit to Be Refiled; Digging Into Breakthrough Approvals; Screen Time and ADHD: https://www.ajmc.com/newsroom/what-were-reading-340b-lawsuit-to-be-refiled-digging-into-breakthrough-approvals-screen-time-and-adhd\\nPause in Risk Adjustment Payments Announced, CMS Blames District Court's Decision: https://www.ajmc.com/newsroom/pause-in-risk-adjustment-payments-announced-cms-blames-district-courts-decision\\nDoctors, Payers Think Transition to Value-Based Care Has Slowed, Survey Says: https://www.ajmc.com/newsroom/doctors-payers-think-transition-to-valuebased-care-has-slowed-survey-says\\nDo Breakthrough Therapies Need More Rigorous Evaluation? https://www.ajmc.com/newsroom/do-breakthrough-therapies-need-more-rigorous-evaluation-\\nEvidence-Based Oncology - July 2018: https://www.ajmc.com/journals/evidence-based-oncology/2018/july-2018"